MAPT and Alzheimer disease: In this way, focus at specific tau phosphorylation site(s) by a kinase multitargeting approach as potential AD therapeutic strategy has been proposed to effectively hamper the multifactorial disease progression (Hilgeroth and Tell, 2013).